Diminished Vitamin D Receptor Protein Levels in Crohn’s Disease Fibroblasts: Effects of Vitamin D

• Published in: Nutrients Vol. 12; no. 4; p. 973
• Main Authors: Gisbert-Ferrándiz, Laura, Cosín-Roger, Jesús, Hernández, Carlos, Macias-Ceja, Dulce C., Ortiz-Masiá, Dolores, Salvador, Pedro, Esplugues, Juan V., Hinojosa, Joaquín, Navarro, Francisco, Calatayud, Sara, Barrachina, María D.
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.04.2020; MDPI
• Subjects: Animals; Antibodies; assays; calcitriol receptors; Cell Movement - drug effects; Collagen; Crohn Disease - drug therapy; Crohn Disease - etiology; Crohn Disease - metabolism; Crohn Disease - pathology; Crohn's disease; Disease Models, Animal; epithelial cells; Epithelial Cells - metabolism; Epithelial Cells - pathology; Experiments; Female; Fibroblasts; Fibroblasts - metabolism; Fibroblasts - physiology; Fibrosis; Gene Expression Regulation - drug effects; Humans; intestines; Intestines - cytology; Intestines - pathology; Male; mice; Mice, Inbred C57BL; nutrients; pathogenesis; patients; protein content; Proteins; Receptors, Calcitriol - genetics; Receptors, Calcitriol - metabolism; Software; Surgery; therapeutics; tissue repair; Vitamin D; Vitamin D - pharmacology; Vitamin D - therapeutic use; Vitamin D Deficiency - complications; Wound Healing - drug effects; United States > US; Madrid Spain; Spain; fibroblasts; fibrosis; vitamin D; vitamin D receptor (VDR); Crohn’s disease
• ISSN: 2072-6643; 2072-6643
• DOI: 10.3390/nu12040973

Vitamin D (VD) deficiency has been associated to Crohn’s disease (CD) pathogenesis, and the exogenous administration of VD improves the course of the disease, but the mechanistic basis of these observations remains unknown. Vitamin D receptor (VDR) mediates most of the biological functions of this hormone, and we aim to analyze here the expression of VDR in intestinal tissue, epithelial cells, and fibroblasts from CD patients. The effects of VD on a fibroblast wound healing assay and murine intestinal fibrosis are also analyzed. Our data show diminished VDR protein levels in surgical resections and epithelial cells from CD patients. In intestinal fibroblasts isolated from damaged tissue of CD patients, we detected enhanced migration and decreased VDR expression compared with both fibroblasts from non-damaged tissue of the same CD patient or control fibroblasts. Treatment with VD increased VDR protein levels, avoided the accelerated migration in CD fibroblasts, and prevented murine intestinal fibrosis induced by the heterotopic transplant model. In conclusion, our study demonstrates diminished VDR protein levels associated with enhanced migration in intestinal fibroblasts from damaged tissue of CD patients. In these cells, VD accumulates VDR and normalizes migration, which supports that CD patients would benefit from the VD anti-fibrotic therapeutic value that we demonstrate in a murine experimental model.